Remifentanil versus alfentanil in a balanced anesthetic technique for total abdominal hysterectomy

Journal of Clinical Anesthesia

Volumn 9, Issue 7, 1997, Pages 532-541

  Kovac, Anthony L ^d   Azad, Said S ^b   Steer, Phyllis ^a   Witkowski, Thomas ^b   Batenhorst, Randal ^c   McNeal, Sally ^c  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Alfentanil; Anesthesia; Balanced; Emergence; Hysterectomy; Remifentanil; Total abdominal

Indexed keywords

ALFENTANIL; PLACEBO; REMIFENTANIL;

ABDOMINAL HYSTERECTOMY; ADULT; ANESTHESIOLOGY; ARTICLE; BALANCED ANESTHESIA; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENDOTRACHEAL INTUBATION; FEMALE; GENERAL ANESTHESIA; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALFENTANIL; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; PIPERIDINES; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030867947     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(97)00140-2     Document Type: Article

References (15)

1. Bovill JG, Sebel PS, Stanley TH: Opioid analgesics in anesthesia: with special reference to their use in cardiovascular anesthesia. Anesthesiology 1984;61:731-55.
2. Monk TG, Mueller M, White PF: Treatment of stress responses during balanced anesthesia. Comparative effects of isoflurane, alfentanil, and trimethaphan. Anesthesiology 1992;76:39-45.
3. Shafer SL, Varvel JR: Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991;74:53-63.
4. James MK: Remifentanil and anaesthesia for the future. Exp Opin Invest Drugs 1994;3:331-400.
5. Feldman PL, James MK, Brackeen MF, et al: Design, synthesis, and pharmacological evaluation of ultrashort-to long-acting opioid analgesics. J Med Chem 1991:34:2202-8.
6. James MK, Feldman PL, Schuster SV, Bilotta JM, Brackeen MF, Leighton HJ: Opioid receptor activity of GI87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991;259:712-8.
7. Egan TD, Lemmens HJ, Fiset P, et al: The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993;79:881-92.
8. Glass PS, Hardman D, Kamiyama Y, et al: Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg 1993;77:1031-40.
9. Westmoreland CL, Hoke JF, Sebel PS, Hug CC Jr, Muir KT: Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993;79:893-903.
10. Landis RJ, Heyman ER, Koch GG: Average partial association in three-way contingency tables: a review and discussion of alternative tests. Int Stat Rev 1978;46:237-54.
11. Breslow NE: Covariance analysis of censored survival data. Biometrics 1974;30:89-99.
12. Philbin DM, Rosow CE, Schneider RC, Koski G, D'Amhra MN: Fentanyl and sufentanil anesthesia revisited: how much is enough? Anesthesiology 1990;73:5-11.
13. Cullen DJ, Eger EI 2d, Stevens WC, et al: Clinical signs of anesthesia. Anesthesiology 1972;36:21-36.
14. Ausems ME, Hug CC Jr, Stanski DR, Burm AG: Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. Anesthesiology 1986;65: 362-73.
15. Dershwitz M, Randel GI, Rosow CE, et al: Initial clinical experience with remifentanil, a new opioid metabolized by esterases. Anesth Analg 1995;81:619-23.